Aurinia Pharmaceuticals Inc. Debt Securities, Held-to-maturity, Fair Value
Discontinued › Balance Sheet › Assets
us-gaap:HeldToMaturitySecuritiesFairValue · last filed 2024-08-01
- 2024-06-30: Debt Securities, Held-to-maturity, Fair Value $330.48M.
- 2024-03-31: Debt Securities, Held-to-maturity, Fair Value $319.91M.
- 2023-12-31: Debt Securities, Held-to-maturity, Fair Value $350.49M.
- 2023-09-30: Debt Securities, Held-to-maturity, Fair Value $337.90M.
| Period end | Debt Securities, Held-to-maturity, Fair Value |
|---|---|
| 2024-06-30 | $330.48M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $319.91M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $350.49M 10-Q · filed 2024-08-01 |
| 2023-09-30 | $337.90M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $350.71M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $361.53M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $389.39M 10-K · filed 2024-02-15 |
| 2022-09-30 | $376.64M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $388.37M 10-Q · filed 2022-08-04 |
| 2021-12-31 | $446.85M 10-K · filed 2023-02-28 |